Balance Sheet
Cash Flow Statement
Change in Account PayablesChange in IntangiblesChange in InventoryGains from Investment SecuritiesNet Debt Issuances and RepaymentsOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed N.V (MYNZ) Cash from Investing Activities: 2022-2023

Historic Cash from Investing Activities for Mainz Biomed N.V (MYNZ) over the last 2 years, with Dec 2023 value amounting to -$261,808.

  • Mainz Biomed N.V's Cash from Investing Activities fell 1663.49% to -$261,808 in Q4 2023 from the same period last year, while for Dec 2023 it was -$1.9 million, marking a year-over-year decrease of 188.37%. This contributed to the annual value of -$198,817 for FY2024, which is 89.53% up from last year.
  • As of Q4 2023, Mainz Biomed N.V's Cash from Investing Activities stood at -$261,808, which was down 132.76% from -$112,478 recorded in Q3 2023.
  • Mainz Biomed N.V's 5-year Cash from Investing Activities high stood at -$14,846 for Q4 2022, and its period low was -$1.4 million during Q1 2023.
  • For the 2-year period, Mainz Biomed N.V's Cash from Investing Activities averaged around -$319,666, with its median value being -$150,106 (2022).
  • The largest annual percentage gain for Mainz Biomed N.V's Cash from Investing Activities in the last 5 years was 71.25% (2023), contrasted with its biggest fall of 1,746.73% (2023).
  • Quarterly analysis of 2 years shows Mainz Biomed N.V's Cash from Investing Activities stood at -$14,846 in 2022, then slumped by 1,663.49% to -$261,808 in 2023.
  • Its last three reported values are -$261,808 in Q4 2023, -$112,478 for Q3 2023, and -$123,625 during Q2 2023.